AbbVie Is Doing 'Very Well' But Jim Cramer's Favorite? Abbott Laboratories

By: via Benzinga
On CNBC's “Mad Money Lightning Round,” Jim Cramer said AbbVie Inc. (NYSE:ABBV) is doing “very, very well.” ...
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.